Max Reinhardt Pacira Bio Sciences, Inc. (PCRX) insider trading activity

PCRX Quotes by TradingView

Max Reinhardt is President, Rest of World of Pacira BioSciences, Inc.. Currently has a direct ownership of 29,225 shares of PCRX, which is worth approximately $554,690. The most recent transaction as insider was on Jun 07, 2023, when has been sold 1,099 shares (Common Stock) at a price of $37.87 per share, resulting in proceeds of $41,619. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 29.2K
0% 3M change
0% 12M change
Total Value Held $554,690

MAX REINHARDT Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 07 2023
SELL
Open market or private sale
$41,619 $37.87 p/Share
1,099 Reduced 3.62%
29,225 Common Stock
Jun 06 2023
SELL
Open market or private sale
$41,095 $38.99 p/Share
1,054 Reduced 3.36%
30,324 Common Stock
Oct 07 2022
SELL
Open market or private sale
$80,040 $58.0 p/Share
1,380 Reduced 4.21%
31,378 Common Stock
Jun 08 2022
BUY
Grant, award, or other acquisition
-
7,950 Added 19.78%
32,250 Common Stock
Jun 07 2022
SELL
Open market or private sale
$150,846 $62.0 p/Share
2,433 Reduced 9.07%
24,400 Common Stock
Jun 06 2022
SELL
Open market or private sale
$172,879 $61.37 p/Share
2,817 Reduced 9.5%
26,833 Common Stock
Apr 21 2022
SELL
Open market or private sale
$719,608 $73.25 p/Share
9,824 Reduced 24.89%
29,650 Common Stock
Apr 21 2022
BUY
Exercise of conversion of derivative security
$531,750 $42.54 p/Share
12,500 Added 24.05%
39,474 Common Stock
Apr 20 2022
SELL
Open market or private sale
$722,438 $73.99 p/Share
9,764 Reduced 26.58%
26,974 Common Stock
Apr 20 2022
BUY
Exercise of conversion of derivative security
$531,750 $42.54 p/Share
12,500 Added 25.39%
36,738 Common Stock
Apr 19 2022
SELL
Open market or private sale
$673,442 $72.25 p/Share
9,321 Reduced 27.77%
24,238 Common Stock
Apr 19 2022
BUY
Exercise of conversion of derivative security
$531,750 $42.54 p/Share
12,500 Added 27.14%
33,559 Common Stock
Apr 18 2022
SELL
Open market or private sale
$657,611 $73.55 p/Share
8,941 Reduced 29.8%
21,059 Common Stock
Apr 18 2022
BUY
Exercise of conversion of derivative security
$531,750 $42.54 p/Share
12,500 Added 29.41%
30,000 Common Stock
Jul 02 2021
SELL
Open market or private sale
$25,159 $59.76 p/Share
421 Reduced 2.35%
17,500 Common Stock
Jun 09 2021
BUY
Grant, award, or other acquisition
-
7,000 Added 28.57%
17,500 Common Stock
Jun 07 2021
SELL
Open market or private sale
$137,819 $60.5 p/Share
2,278 Reduced 17.83%
10,500 Common Stock
Jun 04 2021
SELL
Open market or private sale
$74,591 $61.04 p/Share
1,222 Reduced 8.73%
12,778 Common Stock
Jan 06 2021
SELL
Open market or private sale
$6,689 $60.81 p/Share
110 Reduced 0.78%
14,000 Common Stock
Nov 13 2020
SELL
Open market or private sale
$1,577,250 $63.09 p/Share
25,000 Reduced 64.1%
14,000 Common Stock
Nov 13 2020
BUY
Exercise of conversion of derivative security
$1,063,500 $42.54 p/Share
25,000 Added 39.06%
39,000 Common Stock

Also insider at

OFIX
Orthofix Medical Inc. Healthcare
President, Global Spine
MR

Max Reinhardt

President, Rest of World
Tampa, FL

Track Institutional and Insider Activities on PCRX

Follow Pacira BioSciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCRX shares.

Notify only if

Insider Trading

Get notified when an Pacira Bio Sciences, Inc. insider buys or sells PCRX shares.

Notify only if

News

Receive news related to Pacira BioSciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PCRX